As a result, the 2024 report concludes that the drug development pipeline for Parkinsons is robust, but more progress needs to be made with late-stage testing of treatments to slow the disease, with Cure Parkinsons adding: With the importance of disease-modifying therapies for an eventual cure for Parkinsons, there is a clear need for further initiatives that will facilitate the progression of drugs through the clinical trial pipeline and into subsequent phases of testing. Read more about Parkinsons research here.
Both medications may initially cause nausea or intestinal discomfort, but these symptoms usually subside after a few weeks
Two m slices of formalin-fixed paraffin-embedded (FFPE) tissue were dyed with hematoxillin/eosin (H&E) for determination of metabolic dysfunction-associated fatty liver disease (MASLD) and chromotrope-anilin blue (CAB) trichrome staining for fibrosis assessment
If clinical trials continue to yield positive results, we could soon see this breakthrough medication become an essential part of obesity treatment regimens worldwide
pH-sensitive molecular-switch-containing polymer nanoparticle for breast cancer therapy with ferritinophagy-cascade ferroptosis and tumor immune activation
This information should be interpreted with a qualified healthcare provider to inform personalized dosing strategies that reduce overdose risk while optimizing therapeutic outcomes